img

Global Sickle Cell Disease Treatment Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Sickle Cell Disease Treatment Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Sickle cell disease is a group of disorders that affects hemoglobin, the molecule in red blood cells that delivers oxygen to cells throughout the body. People with this disorderhave atypical hemoglobin molecules called hemoglobin S, which can distort red blood cells into a sickle, or crescent, shape.
Due to the COVID-19 pandemic, the global Sickle Cell Disease Treatment market size was US$ 1920.2 million in 2022 and is forecast to a readjusted size of US$ 4132.3 million by 2034 with a CAGR of 11.4% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Sickle Cell Anemia accounting for % of the Sickle Cell Disease Treatment global market in 2022, is projected to value US$ million by 2034, growing at a revised % CAGR from 2024 to 2034. While Hospitals segment is altered to an % CAGR throughout this forecast period.
The global key companies of Sickle Cell Disease Treatment include AstraZeneca, Eli Lilly, Novartis, Pfizer, Baxter, Emmaus Life Sciences, Bluebird bio, Blood Therapeutics and Sangamo Therapeutics, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
The United States Sickle Cell Disease Treatment market size was US$ million in 2022, while China size was US$ million. The proportion of the United States was % in 2022, while China percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period. As for the Europe Sickle Cell Disease Treatment landscape, Germany is projected to reach US$ million by 2034. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Sickle Cell Disease Treatment market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Sickle Cell Disease Treatment market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Sickle Cell Disease Treatment market. Readers of the report can become informed about current and future trends of the global Sickle Cell Disease Treatment market and how they will impact market growth during the forecast period.



By Company


AstraZeneca
Eli Lilly
Novartis
Pfizer
Baxter
Emmaus Life Sciences
Bluebird bio
Blood Therapeutics
Sangamo Therapeutics
Acceleron Pharma
Arena Pharmaceuticals
Alnylam Pharmaceuticals
Sanofi
CRISPR Therapeutics
Vertex Pharmaceuticals, Inc.
Segment by Type
Sickle Cell Anemia
Sickle Beta Thalassemia
Sickle Hemoglobin C Disease

Segment by Application


Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Sickle Cell Disease Treatment in global and regional level.
Chapter 3Detailed analysis of Sickle Cell Disease Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sickle Cell Disease Treatment revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sickle Cell Disease Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 Sickle Cell Anemia
1.2.3 Sickle Beta Thalassemia
1.2.4 Sickle Hemoglobin C Disease
1.3 Market by Application
1.3.1 Global Sickle Cell Disease Treatment Market Growth Rate by Application: 2018 VS 2022 VS 2034
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Sickle Cell Disease Treatment Market Size (2018-2034)
2.2 Sickle Cell Disease Treatment Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2034
2.3 Global Sickle Cell Disease Treatment Market Size by Region (2018-2024)
2.4 Global Sickle Cell Disease Treatment Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 Sickle Cell Disease Treatment Countries Ranking by Market Size
3 Sickle Cell Disease Treatment Competitive by Company
3.1 Global Sickle Cell Disease Treatment Revenue by Players
3.1.1 Global Sickle Cell Disease Treatment Revenue by Players (2018-2024)
3.1.2 Global Sickle Cell Disease Treatment Market Share by Players (2018-2024)
3.2 Global Sickle Cell Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Sickle Cell Disease Treatment Revenue
3.4 Global Sickle Cell Disease Treatment Market Concentration Ratio
3.4.1 Global Sickle Cell Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Disease Treatment Revenue in 2022
3.5 Global Key Players of Sickle Cell Disease Treatment Head office and Area Served
3.6 Global Key Players of Sickle Cell Disease Treatment, Product and Application
3.7 Global Key Players of Sickle Cell Disease Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Sickle Cell Disease Treatment Breakdown Data by Type
4.1 Global Sickle Cell Disease Treatment Historic Revenue by Type (2018-2024)
4.2 Global Sickle Cell Disease Treatment Forecasted Revenue by Type (2024-2034)
5 Global Sickle Cell Disease Treatment Breakdown Data by Application
5.1 Global Sickle Cell Disease Treatment Historic Market Size by Application (2018-2024)
5.2 Global Sickle Cell Disease Treatment Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Sickle Cell Disease Treatment Revenue by Company (2021-2024)
6.2 North America Sickle Cell Disease Treatment Revenue by Type (2018-2034)
6.3 North America Sickle Cell Disease Treatment Revenue by Application (2018-2034)
6.4 North America Sickle Cell Disease Treatment Revenue by Country (2018-2034)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Sickle Cell Disease Treatment Revenue by Company (2021-2024)
7.2 Europe Sickle Cell Disease Treatment Revenue by Type (2018-2034)
7.3 Europe Sickle Cell Disease Treatment Revenue by Application (2018-2034)
7.4 Europe Sickle Cell Disease Treatment Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Sickle Cell Disease Treatment Revenue by Company (2021-2024)
8.2 Asia Pacific Sickle Cell Disease Treatment Revenue by Type (2018-2034)
8.3 Asia Pacific Sickle Cell Disease Treatment Revenue by Application (2018-2034)
8.4 Asia Pacific Sickle Cell Disease Treatment Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Sickle Cell Disease Treatment Revenue by Company (2021-2024)
9.2 Latin America Sickle Cell Disease Treatment Revenue by Type (2018-2034)
9.3 Latin America Sickle Cell Disease Treatment Revenue by Application (2018-2034)
9.4 Latin America Sickle Cell Disease Treatment Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sickle Cell Disease Treatment Revenue by Company (2021-2024)
10.2 Middle East and Africa Sickle Cell Disease Treatment Revenue by Type (2018-2034)
10.3 Middle East and Africa Sickle Cell Disease Treatment Revenue by Application (2018-2034)
10.4 Middle East and Africa Sickle Cell Disease Treatment Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Sickle Cell Disease Treatment Products and Services
11.1.4 AstraZeneca Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.1.5 AstraZeneca Sickle Cell Disease Treatment SWOT Analysis
11.1.6 AstraZeneca Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Sickle Cell Disease Treatment Products and Services
11.2.4 Eli Lilly Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.2.5 Eli Lilly Sickle Cell Disease Treatment SWOT Analysis
11.2.6 Eli Lilly Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Sickle Cell Disease Treatment Products and Services
11.3.4 Novartis Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.3.5 Novartis Sickle Cell Disease Treatment SWOT Analysis
11.3.6 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Sickle Cell Disease Treatment Products and Services
11.4.4 Pfizer Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.4.5 Pfizer Sickle Cell Disease Treatment SWOT Analysis
11.4.6 Pfizer Recent Development
11.5 Baxter
11.5.1 Baxter Company Details
11.5.2 Baxter Business Overview
11.5.3 Baxter Sickle Cell Disease Treatment Products and Services
11.5.4 Baxter Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.5.5 Baxter Sickle Cell Disease Treatment SWOT Analysis
11.5.6 Baxter Recent Development
11.6 Emmaus Life Sciences
11.6.1 Emmaus Life Sciences Company Details
11.6.2 Emmaus Life Sciences Business Overview
11.6.3 Emmaus Life Sciences Sickle Cell Disease Treatment Products and Services
11.6.4 Emmaus Life Sciences Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.6.5 Emmaus Life Sciences Sickle Cell Disease Treatment SWOT Analysis
11.6.6 Emmaus Life Sciences Recent Development
11.7 Bluebird bio
11.7.1 Bluebird bio Company Details
11.7.2 Bluebird bio Business Overview
11.7.3 Bluebird bio Sickle Cell Disease Treatment Products and Services
11.7.4 Bluebird bio Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.7.5 Bluebird bio Sickle Cell Disease Treatment SWOT Analysis
11.7.6 Bluebird bio Recent Development
11.8 Blood Therapeutics
11.8.1 Blood Therapeutics Company Details
11.8.2 Blood Therapeutics Business Overview
11.8.3 Blood Therapeutics Sickle Cell Disease Treatment Products and Services
11.8.4 Blood Therapeutics Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.8.5 Blood Therapeutics Sickle Cell Disease Treatment SWOT Analysis
11.8.6 Blood Therapeutics Recent Development
11.9 Sangamo Therapeutics
11.9.1 Sangamo Therapeutics Company Details
11.9.2 Sangamo Therapeutics Business Overview
11.9.3 Sangamo Therapeutics Sickle Cell Disease Treatment Products and Services
11.9.4 Sangamo Therapeutics Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.9.5 Sangamo Therapeutics Sickle Cell Disease Treatment SWOT Analysis
11.9.6 Sangamo Therapeutics Recent Development
11.10 Acceleron Pharma
11.10.1 Acceleron Pharma Company Details
11.10.2 Acceleron Pharma Business Overview
11.10.3 Acceleron Pharma Sickle Cell Disease Treatment Products and Services
11.10.4 Acceleron Pharma Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.10.5 Acceleron Pharma Sickle Cell Disease Treatment SWOT Analysis
11.10.6 Acceleron Pharma Recent Development
11.11 Arena Pharmaceuticals
11.11.1 Arena Pharmaceuticals Company Details
11.11.2 Arena Pharmaceuticals Business Overview
11.11.3 Arena Pharmaceuticals Sickle Cell Disease Treatment Products and Services
11.11.4 Arena Pharmaceuticals Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.11.5 Arena Pharmaceuticals Recent Development
11.12 Alnylam Pharmaceuticals
11.12.1 Alnylam Pharmaceuticals Company Details
11.12.2 Alnylam Pharmaceuticals Business Overview
11.12.3 Alnylam Pharmaceuticals Sickle Cell Disease Treatment Products and Services
11.12.4 Alnylam Pharmaceuticals Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.12.5 Alnylam Pharmaceuticals Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Sickle Cell Disease Treatment Products and Services
11.13.4 Sanofi Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.13.5 Sanofi Recent Development
11.14 CRISPR Therapeutics
11.14.1 CRISPR Therapeutics Company Details
11.14.2 CRISPR Therapeutics Business Overview
11.14.3 CRISPR Therapeutics Sickle Cell Disease Treatment Products and Services
11.14.4 CRISPR Therapeutics Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.14.5 CRISPR Therapeutics Recent Development
11.15 Vertex Pharmaceuticals, Inc.
11.15.1 Vertex Pharmaceuticals, Inc. Company Details
11.15.2 Vertex Pharmaceuticals, Inc. Business Overview
11.15.3 Vertex Pharmaceuticals, Inc. Sickle Cell Disease Treatment Products and Services
11.15.4 Vertex Pharmaceuticals, Inc. Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024)
11.15.5 Vertex Pharmaceuticals, Inc. Recent Development
12 Sickle Cell Disease Treatment Market Dynamics
12.1 Sickle Cell Disease Treatment Industry Trends
12.2 Sickle Cell Disease Treatment Market Drivers
12.3 Sickle Cell Disease Treatment Market Challenges
12.4 Sickle Cell Disease Treatment Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global Sickle Cell Disease Treatment Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Sickle Cell Anemia
Table 3. Key Players of Sickle Beta Thalassemia
Table 4. Key Players of Sickle Hemoglobin C Disease
Table 5. Global Sickle Cell Disease Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 6. Global Sickle Cell Disease Treatment Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
Table 7. Global Sickle Cell Disease Treatment Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Sickle Cell Disease Treatment Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 9. Global Sickle Cell Disease Treatment Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Table 10. Global Sickle Cell Disease Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 11. Global Sickle Cell Disease Treatment Market Share by Players (2018-2024)
Table 12. Global Top Sickle Cell Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Disease Treatment as of 2022)
Table 13. Ranking of Global Top Sickle Cell Disease Treatment Companies by Revenue (US$ Million) in 2022
Table 14. Global 5 Largest Players Market Share by Sickle Cell Disease Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 15. Global Key Players of Sickle Cell Disease Treatment, Headquarters and Area Served
Table 16. Global Key Players of Sickle Cell Disease Treatment, Product and Application
Table 17. Global Key Players of Sickle Cell Disease Treatment, Date of Enter into This Industry
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Sickle Cell Disease Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 20. Global Sickle Cell Disease Treatment Revenue Market Share by Type (2018-2024)
Table 21. Global Sickle Cell Disease Treatment Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 22. Global Sickle Cell Disease Treatment Revenue Market Share by Type (2024-2034)
Table 23. Global Sickle Cell Disease Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 24. Global Sickle Cell Disease Treatment Revenue Market Share by Application (2018-2024)
Table 25. Global Sickle Cell Disease Treatment Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 26. Global Sickle Cell Disease Treatment Revenue Market Share by Application (2024-2034)
Table 27. North America Sickle Cell Disease Treatment Revenue by Company (2021-2024) & (US$ Million)
Table 28. North America Sickle Cell Disease Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 29. North America Sickle Cell Disease Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 30. North America Sickle Cell Disease Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 31. North America Sickle Cell Disease Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 32. North America Sickle Cell Disease Treatment Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 33. North America Sickle Cell Disease Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 34. North America Sickle Cell Disease Treatment Revenue by Country (2024-2034) & (US$ Million)
Table 35. Europe Sickle Cell Disease Treatment Revenue by Company (2021-2024) & (US$ Million)
Table 36. Europe Sickle Cell Disease Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 37. Europe Sickle Cell Disease Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 38. Europe Sickle Cell Disease Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 39. Europe Sickle Cell Disease Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 40. Europe Sickle Cell Disease Treatment Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 41. Europe Sickle Cell Disease Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 42. Europe Sickle Cell Disease Treatment Revenue by Country (2024-2034) & (US$ Million)
Table 43. Asia Pacific Sickle Cell Disease Treatment Revenue by Company (2021-2024) & (US$ Million)
Table 44. Asia Pacific Sickle Cell Disease Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 45. Asia Pacific Sickle Cell Disease Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 46. Asia Pacific Sickle Cell Disease Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 47. Asia Pacific Sickle Cell Disease Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 48. Asia-Pacific Sickle Cell Disease Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 49. Asia Pacific Sickle Cell Disease Treatment Revenue by Region (2018-2024) & (US$ Million)
Table 50. Asia Pacific Sickle Cell Disease Treatment Revenue by Region (2024-2034) & (US$ Million)
Table 51. Latin America Sickle Cell Disease Treatment Revenue by Company (2021-2024) & (US$ Million)
Table 52. Latin America Sickle Cell Disease Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 53. Latin America Sickle Cell Disease Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 54. Latin America Sickle Cell Disease Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 55. Latin America Sickle Cell Disease Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 56. Latin America Sickle Cell Disease Treatment Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 57. Latin America Sickle Cell Disease Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 58. Latin America Sickle Cell Disease Treatment Revenue by Country (2024-2034) & (US$ Million)
Table 59. Middle East and Africa Sickle Cell Disease Treatment Revenue by Company (2021-2024) & (US$ Million)
Table 60. Middle East and Africa Sickle Cell Disease Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 61. Middle East and Africa Sickle Cell Disease Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 62. Middle East and Africa Sickle Cell Disease Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 63. Middle East and Africa Sickle Cell Disease Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 64. Middle East and Africa Sickle Cell Disease Treatment Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 65. Middle East and Africa Sickle Cell Disease Treatment Revenue by Country (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Sickle Cell Disease Treatment Revenue by Country (2024-2034) & (US$ Million)
Table 67. AstraZeneca Company Details
Table 68. AstraZeneca Business Overview
Table 69. AstraZeneca Sickle Cell Disease Treatment Product and Services
Table 70. AstraZeneca Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 71. AstraZeneca Sickle Cell Disease Treatment SWOT Analysis
Table 72. AstraZeneca Recent Development
Table 73. Eli Lilly Company Details
Table 74. Eli Lilly Business Overview
Table 75. Eli Lilly Sickle Cell Disease Treatment Product and Services
Table 76. Eli Lilly Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 77. Eli Lilly Sickle Cell Disease Treatment SWOT Analysis
Table 78. Eli Lilly Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Sickle Cell Disease Treatment Product and Services
Table 82. Novartis Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 83. Novartis Sickle Cell Disease Treatment SWOT Analysis
Table 84. Novartis Recent Development
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Sickle Cell Disease Treatment Product and Services
Table 88. Pfizer Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 89. Pfizer Sickle Cell Disease Treatment SWOT Analysis
Table 90. Pfizer Recent Development
Table 91. Baxter Company Details
Table 92. Baxter Business Overview
Table 93. Baxter Sickle Cell Disease Treatment Product and Services
Table 94. Baxter Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 95. Baxter Sickle Cell Disease Treatment SWOT Analysis
Table 96. Baxter Recent Development
Table 97. Emmaus Life Sciences Company Details
Table 98. Emmaus Life Sciences Business Overview
Table 99. Emmaus Life Sciences Sickle Cell Disease Treatment Product and Services
Table 100. Emmaus Life Sciences Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 101. Emmaus Life Sciences Sickle Cell Disease Treatment SWOT Analysis
Table 102. Emmaus Life Sciences Recent Development
Table 103. Bluebird bio Company Details
Table 104. Bluebird bio Business Overview
Table 105. Bluebird bio Sickle Cell Disease Treatment Product and Services
Table 106. Bluebird bio Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 107. Bluebird bio Sickle Cell Disease Treatment SWOT Analysis
Table 108. Bluebird bio Recent Development
Table 109. Blood Therapeutics Company Details
Table 110. Blood Therapeutics Business Overview
Table 111. Blood Therapeutics Sickle Cell Disease Treatment Product and Services
Table 112. Blood Therapeutics Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 113. Blood Therapeutics Sickle Cell Disease Treatment SWOT Analysis
Table 114. Blood Therapeutics Recent Development
Table 115. Sangamo Therapeutics Company Details
Table 116. Sangamo Therapeutics Business Overview
Table 117. Sangamo Therapeutics Sickle Cell Disease Treatment Product and Services
Table 118. Sangamo Therapeutics Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 119. Sangamo Therapeutics Sickle Cell Disease Treatment SWOT Analysis
Table 120. Sangamo Therapeutics Recent Development
Table 121. Acceleron Pharma Company Details
Table 122. Acceleron Pharma Business Overview
Table 123. Acceleron Pharma Sickle Cell Disease Treatment Product and Services
Table 124. Acceleron Pharma Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 125. Acceleron Pharma Sickle Cell Disease Treatment SWOT Analysis
Table 126. Acceleron Pharma Recent Development
Table 127. Arena Pharmaceuticals Company Details
Table 128. Arena Pharmaceuticals Business Overview
Table 129. Arena Pharmaceuticals Sickle Cell Disease Treatment Product and Services
Table 130. Arena Pharmaceuticals Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 131. Arena Pharmaceuticals Recent Development
Table 132. Alnylam Pharmaceuticals Company Details
Table 133. Alnylam Pharmaceuticals Business Overview
Table 134. Alnylam Pharmaceuticals Sickle Cell Disease Treatment Product and Services
Table 135. Alnylam Pharmaceuticals Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 136. Alnylam Pharmaceuticals Recent Development
Table 137. Sanofi Company Details
Table 138. Sanofi Business Overview
Table 139. Sanofi Sickle Cell Disease Treatment Product and Services
Table 140. Sanofi Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 141. Sanofi Recent Development
Table 142. CRISPR Therapeutics Company Details
Table 143. CRISPR Therapeutics Business Overview
Table 144. CRISPR Therapeutics Sickle Cell Disease Treatment Product and Services
Table 145. CRISPR Therapeutics Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 146. CRISPR Therapeutics Recent Development
Table 147. Vertex Pharmaceuticals, Inc. Company Details
Table 148. Vertex Pharmaceuticals, Inc. Business Overview
Table 149. Vertex Pharmaceuticals, Inc. Sickle Cell Disease Treatment Product and Services
Table 150. Vertex Pharmaceuticals, Inc. Sickle Cell Disease Treatment Revenue in Sickle Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 151. Vertex Pharmaceuticals, Inc. Recent Development
Table 152. Sickle Cell Disease Treatment Market Trends
Table 153. Sickle Cell Disease Treatment Market Drivers
Table 154. Sickle Cell Disease Treatment Market Challenges
Table 155. Sickle Cell Disease Treatment Market Restraints
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Sickle Cell Disease Treatment Product Picture
Figure 2. Global Sickle Cell Disease Treatment Market Size by Type (US$ Million): 2018 VS 2022 VS 2034
Figure 3. Global Sickle Cell Disease Treatment Market Share by Type: 2022 VS 2034
Figure 4. Sickle Cell Anemia Features
Figure 5. Sickle Beta Thalassemia Features
Figure 6. Sickle Hemoglobin C Disease Features
Figure 7. Global Sickle Cell Disease Treatment Market Size by Application (US$ Million): 2018 VS 2022 VS 2034
Figure 8. Global Sickle Cell Disease Treatment Market Share by Application: 2022 VS 2034
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Others
Figure 12. Sickle Cell Disease Treatment Report Years Considered
Figure 13. Global Sickle Cell Disease Treatment Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Sickle Cell Disease Treatment Market Size 2018-2034 (US$ Million)
Figure 15. Global Sickle Cell Disease Treatment Market Size Market Share by Region: 2022 VS 2034
Figure 16. Global Sickle Cell Disease Treatment Revenue Market Share by Region in 2018 VS 2022
Figure 17. Global Sickle Cell Disease Treatment Revenue Market Share Forecast by Region (2024-2034)
Figure 18. Global Top 10 Sickle Cell Disease Treatment Countries Ranking by Market Size (US$ Million) in 2022
Figure 19. Global Sickle Cell Disease Treatment Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Figure 20. Global Sickle Cell Disease Treatment Market Share by Players in 2022
Figure 21. Global Top Sickle Cell Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Disease Treatment as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by Sickle Cell Disease Treatment Revenue in 2022
Figure 23. North America Sickle Cell Disease Treatment Revenue Market Share by Company in 2022
Figure 24. North America Sickle Cell Disease Treatment Revenue Market Share by Type (2018-2034)
Figure 25. North America Sickle Cell Disease Treatment Revenue Market Share by Application (2018-2034)
Figure 26. North America Sickle Cell Disease Treatment Revenue Share by Country (2018-2034)
Figure 27. United States Sickle Cell Disease Treatment Revenue (2018-2034) & (US$ Million)
Figure 28. Canada Sickle Cell Disease Treatment Revenue (2018-2034) & (US$ Million)
Figure 29. Europe Sickle Cell Disease Treatment Revenue Market Share by Company in 2022
Figure 30. Europe Sickle Cell Disease Treatment Revenue Market Share by Type (2018-2034)
Figure 31. Europe Sickle Cell Disease Treatment Revenue Market Share by Application (2018-2034)
Figure 32. Europe Sickle Cell Disease Treatment Revenue Share by Country (2018-2034)
Figure 33. Germany Sickle Cell Disease Treatment Revenue (2018-2034) & (US$ Million)
Figure 34. France Sickle Cell Disease Treatment Revenue (2018-2034) & (US$ Million)
Figure 35. U.K. Sickle Cell Disease Treatment Revenue (2018-2034) & (US$ Million)
Figure 36. Italy Sickle Cell Disease Treatment Revenue (2018-2034) & (US$ Million)
Figure 37. Russia Sickle Cell Disease Treatment Revenue (2018-2034) & (US$ Million)
Figure 38. Asia Pacific Sickle Cell Disease Treatment Revenue Market Share by Company in 2022
Figure 39. Asia Pacific Sickle Cell Disease Treatment Revenue Market Share by Type (2018-2034)
Figure 40. Asia Pacific Sickle Cell Disease Treatment Revenue Market Share by Application (2018-2034)
Figure 41. Asia Pacific Sickle Cell Disease Treatment Revenue Share by Region (2018-2034)
Figure 42. China Sickle Cell Disease Treatment Revenue (2018-2034) & (US$ Million)
Figure 43. Japan Sickle Cell Disease Treatment Revenue (2018-2034) & (US$ Million)
Figure 44. South Korea Sickle Cell Disease Treatment Revenue (2018-2034) & (US$ Million)
Figure 45. India Sickle Cell Disease Treatment Revenue (2018-2034) & (US$ Million)
Figure 46. Australia Sickle Cell Disease Treatment Revenue (2018-2034) & (US$ Million)
Figure 47. China Taiwan Sickle Cell Disease Treatment Revenue (2018-2034) & (US$ Million)
Figure 48. Indonesia Sickle Cell Disease Treatment Revenue (2018-2034) & (US$ Million)
Figure 49. Thailand Sickle Cell Disease Treatment Revenue (2018-2034) & (US$ Million)
Figure 50. Malaysia Sickle Cell Disease Treatment Revenue (2018-2034) & (US$ Million)
Figure 51. Latin America Sickle Cell Disease Treatment Revenue Market Share by Company in 2022
Figure 52. Latin America Sickle Cell Disease Treatment Revenue Market Share by Type (2018-2034)
Figure 53. Latin America Sickle Cell Disease Treatment Revenue Market Share by Application (2018-2034)
Figure 54. Latin America Sickle Cell Disease Treatment Revenue Share by Country (2018-2034)
Figure 55. Mexico Sickle Cell Disease Treatment Revenue (2018-2034) & (US$ Million)
Figure 56. Brazil Sickle Cell Disease Treatment Revenue (2018-2034) & (US$ Million)
Figure 57. Argentina Sickle Cell Disease Treatment Revenue (2018-2034) & (US$ Million)
Figure 58. Middle East and Africa Sickle Cell Disease Treatment Revenue Market Share by Company in 2022
Figure 59. Middle East and Africa Sickle Cell Disease Treatment Revenue Market Share by Type (2018-2034)
Figure 60. Middle East and Africa Sickle Cell Disease Treatment Revenue Market Share by Application (2018-2034)
Figure 61. Middle East and Africa Sickle Cell Disease Treatment Revenue Share by Country (2018-2034)
Figure 62. Turkey Sickle Cell Disease Treatment Revenue (2018-2034) & (US$ Million)
Figure 63. Saudi Arabia Sickle Cell Disease Treatment Revenue (2018-2034) & (US$ Million)
Figure 64. UAE Sickle Cell Disease Treatment Revenue (2018-2034) & (US$ Million)
Figure 65. AstraZeneca Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 66. Eli Lilly Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 67. Novartis Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 68. Pfizer Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 69. Baxter Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 70. Emmaus Life Sciences Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 71. Bluebird bio Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 72. Blood Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 73. Sangamo Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 74. Acceleron Pharma Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 75. Arena Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 76. Alnylam Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 77. Sanofi Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 78. CRISPR Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 79. Vertex Pharmaceuticals, Inc. Revenue Growth Rate in Sickle Cell Disease Treatment Business (2018-2024)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries